This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations of Gehyeong Lee: A Pioneer in Pharmaceutical Compounds
Introduction: Gehyeong Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals with his innovative research and development. One of his most notable achievements is his patent related to a specific class of compounds that hold promise for treating various inflammatory and degenerative diseases.
Latest Patents: Gehyeong Lee is credited with one patent titled "7-(3',4′-Dialkoxyphenyl)[1,2,4]-triazolo[1,5-A]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same.” This patent introduces novel triazolo-pyrimidine compounds or their pharmaceutically acceptable salts alongside processes for their preparation. The compounds are envisioned as active ingredients in pharmaceutical compositions designed to treat or prevent a variety of inflammatory conditions, such as asthma, chronic obstructive pulmonary disease, and arthritis, as well as degenerative brain diseases including Alzheimer’s disease and memory impairment.
Career Highlights: Gehyeong Lee works at the Korea Research Institute of Chemical Technology, where he engages in groundbreaking research to develop new pharmaceutical solutions. His expertise and innovative mindset have facilitated advancements in therapeutic compounds aimed at alleviating significant health issues.
Collaborations: Lee has collaborated with esteemed colleagues, including Dong Ju Jeon and Zaesung No, contributing to a collaborative research environment. Together, they aim to leverage their collective knowledge and skills to further enhance the development of effective pharmaceutical treatments.
Conclusion: Gehyeong Lee's dedication to innovation in pharmaceutical compounds showcases his commitment to improving healthcare outcomes. With his patent on triazolo-pyrimidine compounds, he is poised to make a lasting impact on the treatment of chronic diseases and inflammatory conditions. His work at the Korea Research Institute of Chemical Technology, alongside his collaborative efforts, highlights the importance of teamwork in advancing medical science.